Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SL-701
i
Other names:
SL-701, SL 701
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Menarini
Drug class:
EphA2 receptor antagonist, Survivin inhibitor, Stem cell inhibitor, IL-13Rα2 inhibitor
Related drugs:
‹
dasatinib (215)
ALW-II-41-27 (2)
BCY6033 (1)
BT5528 (0)
BT7455 (0)
GLPG 1790 (0)
MM-310 (0)
MVP-S (3)
SVN53-67/M57-KLH peptide vaccine (1)
PC-002 (1)
ABBV-184 (0)
terameprocol (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
NEXI-003 (0)
PDC*lung (0)
LY2181308 (0)
GZ17-6.02 (3)
BBI-503 (0)
OMP-52M51 (0)
dasatinib (215)
ALW-II-41-27 (2)
BCY6033 (1)
BT5528 (0)
BT7455 (0)
GLPG 1790 (0)
MM-310 (0)
MVP-S (3)
SVN53-67/M57-KLH peptide vaccine (1)
PC-002 (1)
ABBV-184 (0)
terameprocol (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
NEXI-003 (0)
PDC*lung (0)
LY2181308 (0)
GZ17-6.02 (3)
BBI-503 (0)
OMP-52M51 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login